EUVIMEDEUVIMED entdecken
Crossref

Naringin Alleviates Intestinal Fibrosis by Inhibiting ER Stress–Induced PAR2 Activation

Jinguo Liu iD, Lei Xu, Li Wang, Qianqian Wang, Liangliang Yu, Shuo Zhang

Inflammatory Bowel Diseases · 2024

DOI: 10.1093/ibd/izae071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von Jinguo Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endoscopy Center, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Flavanones, Fibrosis, Endoplasmic Reticulum Stress, Receptor, PAR-2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: National Natural Science Foundation, Medical Research Development Fund Project of the Beijing Kangmeng Charity Foundation, Key Research Projects of Zhejiang Provincial Administration of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrosis characterized by intestinal strictures is a common complication of Crohn’s disease (CD), without specific antifibrotic drugs, which usually relies on surgical intervention. The transcription factor XBP1, a key component of endoplasmic reticulum (ER) stress, is required for degranulation of mast cells and linked to PAR2 activation and fibrosis. Many studies have confirmed that naringin (NAR) can inhibit ER stress and reduce organ fibrosis. We hypothesized that ER stress activated the PAR2-induced epithelial-mesenchymal transition process by stimulating mast cell degranulation to release tryptase and led to intestinal fibrosis in CD patients; NAR might play an antifibrotic role by inhibiting ER stress–induced PAR2 activation. We report that the expression levels of XBP1, mast cell tryptase, and PAR2 are upregulated in fibrotic strictures of CD patients. Molecular docking simulates the interaction of NAR and spliced XBP1. ER stress stimulates degranulation of mast cells to secrete tryptase, activates PAR2-induced epithelial-mesenchymal transition process, and promotes intestinal fibrosis in vitro and vivo experiments, which is inhibited by NAR. Moreover, F2rl1 (the coding gene of PAR2) deletion in intestinal epithelial cells decreases the antifibrotic effect of NAR. Hence, the ER stress–mast cell tryptase–PAR2 axis can promote intestinal fibrosis, and NAR administration can alleviate intestinal fibrosis by inhibiting ER stress–induced PAR2 activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavanonesFibrosisEndoplasmic Reticulum StressReceptor, PAR-2X-Box Binding Protein 1Epithelial-Mesenchymal TransitionAnimalsHumansMiceCrohn DiseaseMaleMast CellsMice, Inbred C57BLFemaleCell DegranulationMolecular Docking Simulation

Stichwörter der Autor:innen

Crohn’s diseaseER stressPAR2intestinal fibrosisnaringin

Substanzen

FlavanonesnaringinReceptor, PAR-2X-Box Binding Protein 1XBP1 protein, human

Autor:innen und Institutionen

  • Department of Endoscopy Center, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
  • Department of Gastroenterology, The Second Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
  • Department of Surgery, Huangshi Traditional Chinese Medicine Hospital, Hubei Chinese Medical University, Huangshi, China.

ORCID-Profile: Jinguo Liu

Förderung

  • National Natural Science Foundation
  • Medical Research Development Fund Project of the Beijing Kangmeng Charity Foundation
  • Key Research Projects of Zhejiang Provincial Administration of Traditional Chinese Medicine
  • Leading Talents of Scientific and Technological Innovation in the "Ten Thousand Talents Plan" of Zhejiang Province
  • Leading Talents of Scientific and Technological Innovation in the “Ten Thousand Talents Plan” of Zhejiang Province

Zitieren

APA

Liu, J., Xu, L., Wang, L., Wang, Q., Yu, L., & Zhang, S. (2024). Naringin Alleviates Intestinal Fibrosis by Inhibiting ER Stress–Induced PAR2 Activation. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae071

Vancouver

Liu J, Xu L, Wang L, Wang Q, Yu L, Zhang S. Naringin Alleviates Intestinal Fibrosis by Inhibiting ER Stress–Induced PAR2 Activation. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izae071

BibTeX
@article{Liu2024,
  author = {Liu, Jinguo and Xu, Lei and Wang, Li and Wang, Qianqian and Yu, Liangliang and Zhang, Shuo},
  title = {Naringin Alleviates Intestinal Fibrosis by Inhibiting ER Stress–Induced PAR2 Activation},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  doi = {10.1093/ibd/izae071}
}
Kostenlos starten →